Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 03-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -350 | -3,190 | -2,740 | -710 | -3,670 |
| Depreciation Amortization | 35,020 | 170 | 120 | 40 | 130 |
| Other Working Capital | -35,140 | 1,330 | 570 | -400 | 670 |
| Other Operating Activity | -10 | 380 | 610 | 100 | 730 |
| Operating Cash Flow | $-480 | $-1,310 | $-1,440 | $-970 | $-2,140 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -210 | -200 | -20 | -60 |
| Net Acquisitions | 0 | 0 | 0 | 0 | -250 |
| Other Investing Activity | 0 | 80 | 0 | -30 | -220 |
| Investing Cash Flow | $0 | $-130 | $-200 | $-50 | $-530 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 100 | 1,550 | 1,290 | 740 | 2,920 |
| Financing Cash Flow | $100 | $1,550 | $1,290 | $740 | $2,920 |
| Beginning Cash Position | 490 | 390 | 390 | 390 | 140 |
| End Cash Position | 110 | 490 | 40 | 110 | 390 |
| Net Cash Flow | $-380 | $100 | $-350 | $-270 | $250 |
| Free Cash Flow | |||||
| Operating Cash Flow | -480 | -1,310 | -1,440 | -970 | -2,140 |
| Free Cash Flow | -480 | -1,310 | -1,440 | -970 | -2,140 |